||Hwang M, Hariri G, Lyshchik A, Hallahan D, and Fleischer AC. Correlation of Quantified Contrast-Enhanced Sonography to In Vivo Tumor Response. Journal of Ultrasound in Medicine (JUM). 2010;29:597-607.
Hwang M, Lyshchik A, Hariri G, Hallahan D, and Fleischer A. Correlation of Quantified Contrast-Enhanced Sonography to In Vivo Tumor Response. American Institute of Ultrasound in Medicine (AIUM) New Investigator Award Competition. San Diego, March 2010. [oral presentation]
Hwang M, Lyshchik A, Fleischer AC. Molecular Sonography Using Targeted Microbubbles. Ultrasound Quarterly. 2010;26:75-82.
Hwang M, Niermann K, Lyshchik A, and Fleischer AC. Sonographic Assessment of Tumor Vasculature from In Vivo Models to Clinical Applications. Ultrasound Quarterly. 2009;25:175-83.
Hwang M, Moretti L and Lu B. HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy. Curr Med Chem. 2009;16-24:3081-3092.
Hwang M, Perez CA, Moretti L, Lu B. The mTOR signaling network: insights from its role during embryonic development. Curr Med Chem. 2008;15:1192-1208.
Hwang M*, Kim KW*, Moretti L, Jaboin JJ, Cha YI, Lu B: Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy. 2008;4:659-668. *Equal contribution
Hwang M, Yong C, Moretti L, Lu B. Zebrafish as a Model System to Screen Radiation Modifiers. Curr Genomics. 2007;vol 8, no 6:360-369.
Hwang M, Jaboin JJ, Chen H, Courtney R, Cai Q, Lu B. The Aurora Kinase A Polymorphism rs1468055 is Associated with Overall Survival Outcome in Prostate Cancer Patients. American Society for Therapeutic Radiology and Oncology (ASTRO) 51st Annual Meeting. Chicago, November 2009. [oral presentation]
Kan JH, Hwang M, Lowas SR, Hernanz-Schulman M.
Impact of pelvic CT on staging, surveillance, and survival of pediatric patients with Wilms tumor and hepatoblastoma. AJR 2011;May;196(5):W515-8.
Csiki I, Hwang M, Kirby W, Crass J, Ding G, Coffey C, Lu B. Chapter 17D: Use of the Breath-Hold Cone Beam CT in the Stereotactic Radiosurgical Treatment of Stage I Non-Small Cell Lung Cancer Patient. Image-Guided Radiation Therapy (IGRT): A Clinical Perspective. Ed 2011, in press. [textbook chapter]
Sasi N, Hwang M, Jaboin JJ, Csiki L, Lu B. Regulated Cell Death Pathways: New Twists in Modulation of BCL2 Family Function. Mol Cancer Therapeutics. 2009;8(6):1421-9.
Speirs C, Hwang M, Kim S, Chang S, Varki V, Mitchell L, Schleicher S, Lu B. Harnessing the cell death pathway for targeted cancer treatment. Am J Cancer Res. 2011;1(1):43-61.
Jaboin JJ, Hwang M, Perez C, Cooper C, Chen H, Ye C, Cai Q, Wills M, Lu B. No Evidence for Association of the MDM2-309 T/G Promoter Polymorphism with Prostate Cancer Outcomes. Urol Oncol. 2011 May-Jun;29(3):319-23.
Jaboin JJ, Hwang M, Lopater Z, Chen H, Ray GL, Perez C, Cai Q, Wills M, Lu B. The Matrix Metalloproteinase-7 polymorphism Rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1330-5.
Fleischer A, Lyshchik A, Andreotti R, Hwang M, Jones H, Fishman D. Advances in Sonographic Detection of Ovarian Cancer: Depiction of Tumor Neovascularity with Microbubbles. American Journal of Roentgenology (AJR), 2009;194:343-8.
Moretti L, Sebahat O, Hwang M, Lu B, Hallahan D. Chapter 14: Cell Cycle and Vascular Targets for Radiotherapy. Lung Cancer: Principles and Practice. Ed 2010. [textbook chapter]
Perez C, Chen H, Shyr Y, Courtney R, Zheng W, Cai Q, Hwang M, Jaboin J, Wills M, Smith J, Lu B. The EGFR Polymorphism rs884419 is Associated with Freedom from Recurrence in Patients with Resected Prostate Cancer. Journal of Urology. 2010;183:2062-2069.